Monte Rosa Therapeutics, Inc. (GLUE) is a biotechnology company that specializes in developing targeted protein degradation therapies for the treatment of cancer and other diseases. The company focuses on discovering and developing next-generation therapies that can selectively degrade disease-causing proteins, offering a novel approach to drug development. Monte Rosa’s mission is to leverage its expertise […]
Read MoreCheckpoint Therapeutics, Inc. (CKPT) is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for patients with cancer. Their primary aim is to create innovative immunotherapy and targeted therapy options that improve survival rates and quality of life for patients facing challenging cancers. Checkpoint Therapeutics emphasizes both mono and combination therapies to enhance the […]
Read MoreASP Isotopes Inc. (ASPI) is a specialized company focusing on the production and commercialization of isotopes for medical, industrial, and scientific applications. Isotopes are critical elements with unique atomic structures used in various fields, from cancer treatment and diagnostic imaging in healthcare to advanced research and environmental monitoring. ASP Isotopes leverages cutting-edge technology to produce […]
Read MoreFeatured Content The biopharmaceutical and cannabis industries are two sectors undergoing rapid growth and innovation, driven by advancements in medical research and changing consumer demand for both pharmaceuticals and cannabis products. Companies like Context Therapeutics and Organigram are key players in their respective industries, each focusing on cutting-edge technologies and products to meet the needs […]
Read MoreFeatured Content Delcath Systems, Inc. (DCTH) is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of cancer. Founded in 1988, Delcath specializes in regional chemotherapy systems that deliver high doses of chemotherapy directly to tumors while minimizing systemic exposure and side effects. The company’s flagship product, the Delcath Hepatic Delivery […]
Read MoreFeatured Content Kura Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for the treatment of cancer. Headquartered in San Diego, California, Kura Oncology specializes in targeted therapies that aim to inhibit the molecular drivers of cancer, providing more effective and less toxic treatment options for patients. The company’s lead programs are […]
Read MorePerspective Therapeutics, Inc. is a clinical-stage radiopharmaceutical company focused on developing advanced treatments for cancer. The company leverages its proprietary technology, which utilizes the alpha-emitting isotope Pb-212, to deliver targeted radiation directly to cancer cells through specialized peptides. This precision-targeted approach aims to minimize damage to surrounding healthy tissues while effectively treating cancerous cells. One […]
Read MoreQ32 Bio Inc. (QTTB) Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Nkarta, Inc. (NKTX) Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. […]
Read MoreHeron Therapeutics is a biotechnology company that focuses on developing and commercializing treatments to address unmet medical needs, particularly in the areas of pain management and oncology. The company leverages its proprietary Biochronomer drug delivery technology to create innovative therapies that can improve patient outcomes and quality of life.One of Heron Therapeutics’ key products is […]
Read MorePerspective Therapeutics, Inc. (CATX) Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. NextNav Inc. (NN) NextNav Inc. provides next generation positioning, navigation, and timing (PNT) solutions in the United States. Lifeway Foods, Inc. (LWAY) Lifeway Foods, Inc. produces and markets probiotic-based […]
Read MoreTscan Therapeutics Inc (TCRX) is a biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell therapies for the treatment of cancer. The company’s proprietary platform identifies novel TCR targets and engineers TCRs directed against these targets for use in TCR-T cell therapies. These therapies aim to harness the power of the […]
Read MoreCardiff Oncology Inc. (CRDF) is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company’s primary objective is to leverage its expertise in oncology and drug development to create therapies that can address unmet medical needs and improve the lives of patients battling cancer. Three main drivers of growth for Cardiff Oncology […]
Read MoreVerastem, Inc. (VSTM) is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company was founded in 2010 and is headquartered in Needham, Massachusetts. Verastem’s mission is to improve the lives of patients suffering from cancer by targeting the underlying biology of cancer stem cells, […]
Read MoreSpire Global, Inc. (SPIR) Spire Global, Inc. provides subscription-based data, insights, predictive analytics, and related project-based services worldwide. Dianthus Therapeutics, Inc. (DNTH) Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. Immunome, Inc. (IMNM) Immunome, Inc. operates as a biotechnology company […]
Read MoreNkarta Inc (NKTS) is a biotechnology company focused on the research, development, and commercialization of natural killer (NK) cell therapies for the treatment of cancer. NK cells are a type of immune cell that can identify and destroy cancerous or infected cells in the body. Nkarta’s innovative approach involves harnessing and enhancing the innate power […]
Read More